These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 36334291
1. Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection. Ren L, Cheng H, Chen J, Deng J, Wang D, Xie Q, Wakimoto H, Hua L, Gong Y. J Neurosurg; 2023 Jul 01; 139(1):49-58. PubMed ID: 36334291 [Abstract] [Full Text] [Related]
2. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy. Zhi M, Girvigian MR, Miller MJ, Chen JC, Schumacher AJ, Rahimian J, Lodin K. World Neurosurg; 2019 Feb 01; 122():e1153-e1161. PubMed ID: 30447464 [Abstract] [Full Text] [Related]
3. Skull base atypical meningioma: long term surgical outcome and prognostic factors. Wang YC, Chuang CC, Wei KC, Hsu YH, Hsu PW, Lee ST, Wu CT, Tseng CK, Wang CC, Chen YL, Jung SM, Chen PY. Clin Neurol Neurosurg; 2015 Jan 01; 128():112-6. PubMed ID: 25486076 [Abstract] [Full Text] [Related]
4. Early Postoperative Adjuvant Radiotherapy Versus Active Monitoring After Gross Total Resection for Atypical Meningiomas: Factors Associated with Early Recurrence. Gurses ME, Zengin HY, Shikhaliyeva A, Askun CS, Mut M. Turk Neurosurg; 2023 Jan 01; 33(4):635-641. PubMed ID: 37470513 [Abstract] [Full Text] [Related]
5. Early adjuvant radiotherapy in the treatment of atypical meningioma. Jenkinson MD, Waqar M, Farah JO, Farrell M, Barbagallo GM, McManus R, Looby S, Hussey D, Fitzpatrick D, Certo F, Javadpour M. J Clin Neurosci; 2016 Jun 01; 28():87-92. PubMed ID: 26775147 [Abstract] [Full Text] [Related]
6. Effectiveness of Postoperative Radiotherapy in Patients with Atypical Meningiomas After Gross Total Resection: Analysis of 260 Cases. Zeng Q, Tian Z, Gao Q, Xu P, Shi F, Zhang J, Guo Z. World Neurosurg; 2022 Jun 01; 162():e580-e586. PubMed ID: 35307589 [Abstract] [Full Text] [Related]
7. Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Sun SQ, Kim AH, Cai C, Murphy RK, DeWees T, Sylvester P, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Leonard JR, Evans J, Simpson JR, Robinson CG, Perrin RJ, Huang J, Chicoine MR. Neurosurgery; 2014 Oct 01; 75(4):347-54; discussion 354-5; quiz 355. PubMed ID: 24932707 [Abstract] [Full Text] [Related]
8. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma. Rydzewski NR, Lesniak MS, Chandler JP, Kalapurakal JA, Pollom E, Tate MC, Bloch O, Kruser T, Dalal P, Sachdev S. Cancer; 2018 Feb 15; 124(4):734-742. PubMed ID: 29131312 [Abstract] [Full Text] [Related]
9. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution. Hua L, Zhu H, Li J, Tang H, Kuang D, Wang Y, Tang F, Chen X, Zhou L, Xie Q, Gong Y. J Neurosurg; 2018 Jun 15; 128(6):1698-1706. PubMed ID: 28820306 [Abstract] [Full Text] [Related]
11. Radiopathologic predictors of recurrence in patients with a gross totally resected atypical meningioma. Anand SK, Sardari H, Sadeghsalehi A, Bagheri SR, Eden SV, Lawton MT, Alimohammadi E. Neurol Res; 2022 May 15; 44(5):468-474. PubMed ID: 34967283 [Abstract] [Full Text] [Related]
12. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma. Graffeo CS, Leeper HE, Perry A, Uhm JH, Lachance DJ, Brown PD, Ma DJ, Van Gompel JJ, Giannini C, Johnson DR, Raghunathan A. World Neurosurg; 2017 Jul 15; 103():655-663. PubMed ID: 28450233 [Abstract] [Full Text] [Related]
13. Adjuvant radiotherapy in grossly total resected grade II atypical meningiomas: a protective effect on recurrence? Zoli M, Della Pepa GM, Carretta A, Bongetta D, Somma T, Zoia C, Raffa G. J Neurosurg Sci; 2022 Jun 15; 66(3):240-250. PubMed ID: 34763391 [Abstract] [Full Text] [Related]
14. Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis. Chun SW, Kim KM, Kim MS, Kang H, Dho YS, Seo Y, Kim JW, Kim YH, Park CK. Radiat Oncol; 2021 Feb 17; 16(1):34. PubMed ID: 33596974 [Abstract] [Full Text] [Related]
15. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy. Chen WC, Magill ST, Wu A, Vasudevan HN, Morin O, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Braunstein SE, Raleigh DR. J Neurosurg; 2018 Apr 06; 130(2):443-450. PubMed ID: 29624151 [Abstract] [Full Text] [Related]
16. Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre. Wang F, Xu D, Liu Y, Lin Y, Wei Q, Gao Q, Lei S, Guo F. Acta Neurochir (Wien); 2019 Dec 06; 161(12):2563-2570. PubMed ID: 31641861 [Abstract] [Full Text] [Related]
17. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas. Keric N, Kalasauskas D, Freyschlag CF, Gempt J, Misch M, Poplawski A, Lange N, Ayyad A, Thomé C, Vajkoczy P, Meyer B, Ringel F. J Neurooncol; 2020 Jan 06; 146(2):347-355. PubMed ID: 31900826 [Abstract] [Full Text] [Related]
18. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy. Rubino F, Schur S, McGovern SL, Kamiya-Matsuoka C, DeMonte F, Raza SM. J Neurosurg; 2023 Sep 01; 139(3):798-809. PubMed ID: 36738459 [Abstract] [Full Text] [Related]
19. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas. Unterberger A, Nguyen T, Duong C, Kondajji A, Kulinich D, Yang I. J Neurooncol; 2021 Apr 01; 152(2):205-216. PubMed ID: 33635510 [Abstract] [Full Text] [Related]
20. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma. Zhu H, Bi WL, Aizer A, Hua L, Tian M, Den J, Tang H, Chen H, Wang Y, Mao Y, Dunn IF, Xie Q, Gong Y. Cancer Med; 2019 Jan 01; 8(1):13-20. PubMed ID: 30680963 [Abstract] [Full Text] [Related] Page: [Next] [New Search]